This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:co-infections [06.07.2011] – [Co-infections] paulalbert | home:diseases:co-infections [06.07.2011] – paulalbert | ||
---|---|---|---|
Line 6: | Line 6: | ||
A variety of bacteria, fungi, and viruses are commonly described as co-infections. These include: // | A variety of bacteria, fungi, and viruses are commonly described as co-infections. These include: // | ||
- | Because the Marshall Protocol activates the innate immune response, a system that is responsive to a range of microbes, the MP targets these infections. Patients on the MP experience an immunopathological reaction in eliminating any microbes including those labelled as co-infections. | + | Because the Marshall Protocol activates the innate immune response, a system that is responsive to a range of microbes, |
Line 18: | Line 18: | ||
- | ===== Marshall Protocol targets co-infections ===== | + | ===== Marshall Protocol targets |
< | < | ||
- | Using the VDR agonist, olmesartan, the MP activates the innate immune response. The innate immune response is effective against a range of microbes | + | Using the VDR agonist, olmesartan, the MP activates the innate immune response. The innate immune response is effective against a range of microbes including |
{{section>: | {{section>: |